Bone Biologics Corporation (BBLG)

CIK 0001419554 · Healthcare · Biotechnology

Recent Filing Index

Form Filed Qtr End F_Period 8K: Earnings Release
Latest Q1-2026 —
Latest FY-2025 —
Q3-2025 —
Q2-2025 —
Q1-2025 —
FY-2024 —
Q3-2024 —
Q2-2024 —
Q1-2024 —
FY-2023 —
FY-2022
Q3-2023 —
Q2-2023 —

Filing Summary

Report Name | Notes Fiscal Period (Annual) Fiscal Period (Quarter)
Cover
Statements
Consolidated Balance Sheets
Consolidated Balance Sheets (P)
Consolidated Statements of Operations
Consolidated Statement of Stockholders' Equity
Consolidated Statement of Stockholders' Equity (unaudited) (P)
Consolidated Statements of Cash Flows
Notes
Commitments and Contingencies
Common Stock Warrants
Cybersecurity Risk Management and Strategy Disclosure
—
Income Taxes
—
Insider Trading Arrangements
Pay Vs Performance Disclosure
Research and Development
Segment Information
Stock-based Compensation
Stockholders Deficit
—
Stockholders Equity
—
Subsequent Events
Summary of Significant Accounting Policies
The Company
The Company, General Organization, and Going Concern and Liquidity
—
Warrant Liability